Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for XGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 39.72M
March 31, 2026 37.52M
December 31, 2025 41.75M
September 30, 2025 44.68M
June 30, 2025 37.73M
March 31, 2025 33.89M
December 31, 2024 35.86M
September 30, 2024 30.74M
June 30, 2024 31.72M
March 31, 2024 30.82M
December 31, 2023 34.25M
September 30, 2023 33.42M
June 30, 2023 32.28M
March 31, 2023 43.30M
December 31, 2022 45.17M
September 30, 2022 45.41M
June 30, 2022 44.02M
March 31, 2022 45.89M
December 31, 2021 39.23M
September 30, 2021 36.97M
June 30, 2021 36.94M
March 31, 2021 36.05M
December 31, 2020 37.17M
September 30, 2020 35.52M
June 30, 2020 32.67M
Date Value
March 31, 2020 34.11M
December 31, 2019 32.65M
September 30, 2019 34.09M
June 30, 2019 33.80M
March 31, 2019 34.23M
December 31, 2018 36.05M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015 36.81M
September 30, 2015 34.40M
June 30, 2015 31.49M
March 31, 2015 33.23M
December 31, 2014 31.20M
September 30, 2014 28.60M
June 30, 2014 22.35M
March 31, 2014

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. 335.00M
BioRestorative Therapies, Inc. 1.615M
CareDx, Inc. 107.39M
Natera, Inc. 836.00M
Sera Prognostics, Inc. 27.36M

Total Liabilities (Quarterly) Related Metrics